Search results
BioMarin (BMRN) Q3 Earnings Beat, Sales Miss, Ups Voxzogo View
Zacks via Yahoo Finance· 2 years agoBioMarin Pharmaceutical BMRN reported adjusted earnings of 45 cents per share in third-quarter 2022,...
BioMarin's (BMRN) Q2 Earnings Top, Voxzogo Drives Sales
Zacks via Yahoo Finance· 2 years agoBioMarin Pharmaceutical BMRN reported second-quarter 2022 adjusted earnings of 59 cents per share,...
BioMarin (BMRN) Posts Q4 Earnings Beat, Upbeat Voxzogo Sales
Zacks via Yahoo Finance· 2 months agoBioMarin Pharmaceutical BMRN reported fourth-quarter 2023 adjusted earnings per share of 49 cents,...
Sanofi (SNY) Q3 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. Sanofi (NASDAQ: SNY)Q3 2022 Earnings CallOct 28, 2022, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call...
BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 years agoA month has gone by since the last earnings report for BioMarin Pharmaceutical (BMRN). Shares have...
TG Therapeutics (TGTX) Gets FDA Nod for Multiple Sclerosis Drug
Zacks via Yahoo Finance· 1 year agoThe FDA approves TG Therapeutics' (TGTX) Briumvi (ublituximab-xiiy) for treating relapsing forms of...
BioMarin (BMRN) Q3 Earnings in Line, Sales Miss, '23 View Cut
Zacks via Yahoo Finance· 6 months agoBioMarin's (BMRN) Q3 earnings are in line with estimates but miss the mark on sales. The company...
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoInovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript November 9, 2023 Inovio...
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.
Barrons.com· 3 weeks agoBARRON'S COVER - MAIN Understanding the products from pharmaceutical companies could be the most...
BioMarin (BMRN) Q4 Earnings Miss, Sales Beat, Stock Down
Zacks via Yahoo Finance· 1 year agoBioMarin (BMRN) reports mixed Q4 results as it misses estimates for earnings but beats the same for...
